Miin Roh
Featured in: 
jamanetwork.com
Articles
-
Dec 11, 2024 |
jamanetwork.com | Helen Tesfaye |Julie M. Paik |Miin Roh |Phyo T. Htoo
Empagliflozin and the Risk of Retinopathy in Patients With Type 2 Diabetes Key PointsQuestion Is there an association between empagliflozin and the risk of nonproliferative diabetic retinopathy (NPDR) and diabetic retinopathy (DR) progression in patients with type 2 diabetes (T2D)?
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →